Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Dare Bioscience, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 24 | 23 | −1 |
| Shares | 827.0K | 904.3K | +77.3K (+9.3%) |
| Value | $2.39M | $2.16M | −$228.8K (−9.6%) |
New holders (2)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Global Retirement Partners, LLC | 4,359 | $10.4K | 0.00% |
| Raymond James Financial Inc | 1,684 | $4.03K | 0.00% |
Sold out (3)
Institutions that held Dare Bioscience, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Mather Group, LLC. | 84 | $243 |
| Advisor Group Holdings, Inc. | 25 | $72 |
| JPMorgan Chase & Co | 19 | $55 |